Tcg Crossover Management, LLC Aerovate Therapeutics, Inc. Put Options Transaction History
Tcg Crossover Management, LLC
- $668 Million
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AVTE
# of Institutions
94Shares Held
27.5MCall Options Held
185KPut Options Held
129K-
Ra Capital Management, L.P. Boston, MA9.19MShares$20.1 Million0.23% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA3.76MShares$8.23 Million0.35% of portfolio
-
Atlas Venture Life Science Advisors, LLC1.8MShares$3.94 Million0.4% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$3.09 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$2.42 Million0.0% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $53.5M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...